| Malignant disease | |||||
|---|---|---|---|---|---|
| Malignant disease / Antibody responsive malignancy | |||||
| amivantamab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA850 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for infusion | |||||
| Rybrevant (Janssen-Cilag Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| atezolizumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA525 NICE TA739 NICE TA520 NICE TA584 NICE TA705 NICE TA823 NICE TA638 NICE TA639 NICE TA666 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for infusion | |||||
| Tecentriq (Roche Products Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| avelumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA517 NICE TA691 NICE TA645 NICE TA788 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Bavencio (Merck Serono Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| bevacizumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA118 NICE TA212 NICE TA242 NICE TA178 NICE TA214 NICE TA263 NICE TA284 NICE TA285 NICE TA666 NICE TA946 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for infusion | |||||
| Avastin (Roche Products Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| blinatumomab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA450 NICE TA589 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Powder for solution for infusion | |||||
| Blincyto (Amgen Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| brentuximab vedotin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA478 NICE TA641 NICE TA524 NICE TA577 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Powder for solution for infusion | |||||
| Adcetris (Takeda UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| cemiplimab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA802 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for infusion | |||||
| Libtayo (Regeneron UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| cetuximab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA145 NICE TA473 NICE TA242 NICE TA439 NICE TA668 |
|||
|
NICE does not recommend this medicine for the following indication
TA242 - Cetuximab monotherapy or combination chemotherapy is not recommended for the treatment of patients with metastatic colorectal cancer that has progressed after first-line chemotherapy. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Erbitux (Merck Serono Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| daratumumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA763 NICE TA783 NICE TA897 NICE TA917 NICE TA959 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for injection | |||||
| Darzalex (Janssen-Cilag Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Darzalex (Janssen-Cilag Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| dinutuximab beta [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA538 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| dostarlimab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA779 NICE TA963 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| durvalumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA798 NICE TA944 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| elotuzumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| gemtuzumab ozogamicin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA545 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Powder for solution for infusion | |||||
| Mylotarg (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| inotuzumab ozogamicin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA541 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Powder for solution for infusion | |||||
| Besponsa (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| ipilimumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA268 NICE TA319 NICE TA400 NICE TA716 NICE TA724 NICE TA780 NICE TA818 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Yervoy (Bristol-Myers Squibb Pharmaceuticals Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| isatuximab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA658 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Sarclisa (Sanofi) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| mogamulizumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA754 NICE TA754 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Poteligeo (Kyowa Kirin Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| nivolumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA384 NICE TA400 NICE TA684 NICE TA417 NICE TA780 NICE TA964 NICE TA462 NICE TA655 NICE TA713 NICE TA724 NICE TA876 NICE TA530 NICE TA817 NICE TA707 NICE TA746 NICE TA857 NICE TA865 NICE TA716 NICE TA736 NICE TA818 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for infusion | |||||
| Opdivo (Bristol-Myers Squibb Pharmaceuticals Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| obinutuzumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA343 NICE TA513 NICE TA629 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Gazyvaro (Roche Products Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| panitumumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA242 NICE TA439 |
|||
|
NICE does not recommend this medicine for the following indication
TA242 - Panitinumab monotherapy is not recommended for the treatment of patients with metastatic colorectal cancer that has progressed after first-line chemotherapy. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Vectibix (Amgen Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| pembrolizumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA357 NICE TA366 NICE TA766 NICE TA837 NICE TA428 NICE TA531 NICE TA683 NICE TA770 NICE TA692 NICE TA772 NICE TA540 NICE TA967 NICE TA650 NICE TA830 NICE TA858 NICE TA661 NICE TA709 NICE TA914 NICE TA983 NICE TA737 NICE TA997 NICE TA801 NICE TA851 NICE TA939 NICE TA904 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for infusion | |||||
| Keytruda (Merck Sharp & Dohme (UK) Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| pertuzumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA424 NICE TA509 NICE TA569 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Perjeta (Roche Products Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| polatuzumab vedotin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA649 NICE TA874 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Powder for solution for infusion | |||||
| Polivy (Roche Products Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| ramucirumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA378 NICE TA403 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for infusion | |||||
| Cyramza (Eli Lilly and Company Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| rituximab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
|||
|
Rituximab for malignancy
The Joint Prescribing Group (JPG) agreed not to approve this medicine for use at Homerton University Hospital Foundation Trust as the trust does not provide this specialist service. The JPG recommends the funding of this medicine to enable it to be prescribed or initiated at specialist hospitals accredited to provide this medicine, provided it is used in accordance with the relevant NICE Technology Appraisal(s). |
|||||
| Solution for infusion | |||||
| MabThera (Roche Products Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Rixathon (Sandoz Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Truxima (Celltrion Healthcare UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| sacituzumab govitecan [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA819 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Powder for solution for infusion | |||||
| Trodelvy (Gilead Sciences Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| siltuximab | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| trastuzumab [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA34 NICE TA257 NICE TA509 NICE TA208 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Herceptin (Roche Products Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for infusion | |||||
| Herceptin (Roche Products Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Herzuma (Celltrion Healthcare UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Ontruzant (Organon Pharma (UK) Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Trazimera (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Zercepac (Accord-UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| trastuzumab deruxtecan [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA704 NICE TA862 NICE TA992 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Powder for solution for infusion | |||||
| Enhertu (Daiichi Sankyo UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| trastuzumab emtansine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA458 NICE TA632 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Powder for solution for infusion | |||||
| Kadcyla (Roche Products Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Malignant disease / Carcinoid syndrome | |||||
| telotristat ethyl | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Malignant disease / Immunotherapy responsive malignancy | |||||
| Bacillus Calmette-Guérin [Specialist drug] | Hospital only | ||||
| Powder for reconstitution for instillation | |||||
| OncoTICE (Merck Sharp & Dohme (UK) Ltd) | Hospital only | ||||
| aldesleukin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Proleukin (Clinigen Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| interferon gamma-1b | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Immukin (Clinigen Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| lenalidomide [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA322 NICE TA171 NICE TA586 NICE TA587 NICE TA627 NICE TA680 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| mifamurtide [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA235 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| pomalidomide [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA427 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| talimogene laherparepvec [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA410 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| thalidomide [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA228 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Malignant disease / Targeted therapy responsive malignancy | |||||
| abemaciclib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA563 NICE TA725 NICE TA810 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| acalabrutinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA689 NICE TA689 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| afatinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA310 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| aflibercept [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA294 NICE TA305 NICE TA346 NICE TA409 NICE TA486 NICE TA307 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for injection | |||||
| Eylea (Bayer Plc) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Zaltrap (Sanofi) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| alectinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA536 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| alpelisib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA816 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| asciminib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA813 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| avapritinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| axitinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA333 NICE TA645 NICE TA650 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| bortezomib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA370 NICE TA311 NICE TA228 NICE TA129 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Powder for solution for injection | |||||
| Velcade (Janssen-Cilag Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| bosutinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA401 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| brigatinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA571 NICE TA670 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Form unstated | |||||
| Alunbrig (Takeda UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| cabozantinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA463 NICE TA542 NICE TA964 NICE TA516 NICE TA928 NICE TA849 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Form unstated | |||||
| Cometriq (Ipsen Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| carfilzomib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA657 NICE TA695 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Powder for solution for infusion | |||||
| Kyprolis (Amgen Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| ceritinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA395 NICE TA500 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| cobimetinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA414 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| crizotinib [Specialist drug] | Hospital only |
NICE TA406 NICE TA422 NICE TA529 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| dabrafenib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA321 NICE TA396 NICE TA544 NICE TA898 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| dacomitinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA595 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| dasatinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA426 NICE TA425 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| encorafenib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA562 NICE TA668 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| entrectinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA643 NICE TA644 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| erlotinib [Specialist drug] | Hospital only |
NICE TA227 NICE TA258 NICE TA374 NICE TA374 |
|||
|
Erlotinib is not approved for use at HUHFT for indications not recommended by NICE TA227 and TA374
NICE does not recommend this medicine for the following indications TA227 - Erlotinib monotherapy is not recommended for maintenance treatment in patients with locally advanced or metastatic non-small-cell lung cancer who have stable disease after platinum-based first-line chemotherapy. TA374 - Erlotinib is not recommended for treating locally advanced or metastatic non‑small‑cell lung cancer that has progressed after non‑targeted chemotherapy in patients with tumours that are EGFR‑TK mutation‑negative. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| everolimus | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA421 NICE TA432 NICE TA449 |
|||
|
Afinitor® NICE TA498 Certican® NICE TA348 Certican® NICE TA481 |
|||||
| fedratinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA756 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| gefitinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA192 NICE TA374 |
|||
|
NICE does not recommend this medicine for the following indication
TA374 - Gefitinib is not recommended for treating locally advanced or metastatic non‑small‑cell lung cancer that has progressed after non‑targeted chemotherapy in patients with tumours that are EGFR‑TK mutation‑positive.
|
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| gilteritinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA642 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| glasdegib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| ibrutinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA429 NICE TA891 NICE TA502 NICE TA795 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| idelalisib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA359 NICE TA604 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| imatinib [Specialist drug] | Hospital only |
NICE TA326 NICE TA70 NICE TA86 NICE TA209 NICE TA426 NICE TA425 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
|
Imatinib 600mg daily and 800mg daily doses are not approved for used as per NICE TA209 and TA425
NICE does not recommend the use of imatinib at 600mg daily and 800mg daily doses for the following indications NICE TA209 - Imatinib 600 mg daily or 800 mg daily is not recommended for unresectable or metastatic, or both, gastro-intestinal stromal tumours whose disease has progressed after treatment with imatinib 400 mg daily. NICE TA425 - High-dose imatinib (600 mg in the chronic phase or 800 mg in the accelerated and blast-crisis phases) is not recommended for treating Philadelphia-chromosome-positive CML in adults whose disease is imatinib-resistant. |
|||||
| ixazomib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA870 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| lapatinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA257 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| larotrectinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA630 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral solution | |||||
| Vitrakvi (Bayer Plc) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| lenvatinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA535 NICE TA551 NICE TA498 NICE TA858 NICE TA904 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| lorlatinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA628 NICE TA909 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| midostaurin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA523 NICE TA728 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| mobocertinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA855 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| neratinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA612 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| nilotinib [Specialist drug] | Hospital only |
NICE TA426 NICE TA425 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| nintedanib | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA347 NICE TA379 NICE TA864 NICE TA747 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| niraparib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA673 NICE TA784 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| olaparib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA908 NICE TA946 NICE TA962 NICE TA886 NICE TA887 NICE TA951 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| osimertinib [Specialist drug] | Hospital only |
NICE TA653 NICE TA654 NICE TA761 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| palbociclib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA495 NICE TA836 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| pazopanib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA215 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| pemigatinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA722 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| ponatinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA451 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| pralsetinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA812 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| regorafenib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA488 NICE TA555 NICE TA866 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| ribociclib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA496 NICE TA687 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| rucaparib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA1007 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| ruxolitinib [Specialist drug] | Hospital only |
NICE TA386 NICE TA921 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| selpercatinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA742 NICE TA760 NICE TA911 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| sorafenib [Specialist drug] | Hospital only |
NICE TA178 NICE TA474 NICE TA535 |
|||
|
Sorafenib is approved for use at HUHFT only for the treatment of advanced hepatocellular carcinoma as per NICE TA474
NICE TA474 - Sorafenib is approved for use at HUHFT only for the treatment of advanced hepatocellular carcinoma. NICE TA535 - Sorafenib is not approved for use at HUHFT for the treatment of differentiated thyroid cancer after radioactive iodine as the trust does not provide this service.
|
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| sotorasib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA781 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| sunitinib [Specialist drug] | Hospital only |
NICE TA169 NICE TA179 NICE TA178 NICE TA449 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Sunitinib is approved for use at HUHFT only for the treatment of gastrointestinal stromal tumour (NICE TA179)
NICE TA179 - Sunitinib is approved for use at HUHFT only for the treatment of gastrointestinal stromal tumour. NICE TA169, TA178 and TA479 - Sunitinib is not approved for use at HUHFT for the treatment of the following conditions as the trust does not offer these services.
|
|||||
| temsirolimus [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA178 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for infusion | |||||
| Torisel (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| tepotinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA789 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| tivozanib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA512 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| trametinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA396 NICE TA544 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| tucatinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA786 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| vandetanib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA550 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| vemurafenib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA269 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| venetoclax [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA561 NICE TA663 NICE TA796 NICE TA765 NICE TA787 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| vismodegib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA489 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| zanubrutinib [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA833 NICE TA931 NICE TA1001 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Malignant disease / Cytotoxic responsive malignancy | |||||
| amsacrine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| arsenic trioxide [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA526 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Trisenox (Teva UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| asparaginase [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| azacitidine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA218 NICE TA399 NICE TA827 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Powder for suspension for injection | |||||
| Azacitidine (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Vidaza (Bristol-Myers Squibb Pharmaceuticals Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| bendamustine hydrochloride [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA216 NICE TA472 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| bexarotene [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| bleomycin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| busulfan [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| cabazitaxel [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA391 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| capecitabine [Specialist drug] | Hospital only |
NICE TA263 NICE TA212 NICE TA191 NICE TA61 NICE TA100 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| carboplatin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA284 NICE TA285 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Carboplatin (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| carmustine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA121 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| chlorambucil [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA343 NICE TA344 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| chlormethine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA720 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| cisplatin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Cisplatin (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| cladribine | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA616 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Litak (Lipomed GmbH) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Leustat (Atnahs Pharma UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| clofarabine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Clofarabine (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| crisantaspase [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Erwinase (Porton Biopharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| cyclophosphamide | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Cyclophosphamide (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| cytarabine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Cytarabine (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| dacarbazine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Dacarbazine (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| daunorubicin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| daunorubicin with cytarabine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA552 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| decitabine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Powder for solution for infusion | |||||
| Dacogen (Janssen-Cilag Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| docetaxel [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA101 NICE TA509 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Docetaxel (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| doxorubicin hydrochloride [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA389 NICE TA465 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Doxorubicin hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Doxorubicin hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| epirubicin hydrochloride [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Epirubicin hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Pharmorubicin (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Epirubicin hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| eribulin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA423 NICE TA515 |
|||
|
NICE TA515
The JPG agreed not to approve this medicine for treating locally advanced or metastatic breast cancer in adults who have had only 1 chemotherapy regimen as currently NICE cannot recommend its use. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Halaven (Eisai Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
NICE TA515
The JPG agreed not to approve this medicine for treating locally advanced or metastatic breast cancer in adults who have had only 1 chemotherapy regimen as currently NICE cannot recommend its use. |
|||||
| estramustine phosphate [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| etoposide [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Etopophos (Neon Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Etoposide (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| fludarabine phosphate [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA119 NICE TA29 |
|||
|
NICE does not recommend this medicine for the following indication
TA29 - Fludarabine monotherapy is not recommended for the first-line treatment of chronic lymphocytic leukaemia. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Fludarabine phosphate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Fludarabine phosphate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Fludara (Sanofi) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| fluorouracil | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Fluorouracil (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Fluorouracil (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| gemcitabine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA25 NICE TA116 NICE TA285 NICE TA389 NICE TA476 |
|||
|
NICE does not recommend this medicine for the following indications
TA285 - Bevacizumab in combination with gemcitabine and carboplatin is not recommended within its marketing authorisation, that is, for the treatment of the first recurrence of platinum-sensitive advanced ovarian cancer (including fallopian tube and primary peritoneal cancer) that has not been previously treated with bevacizumab or other vascular endothelial growth factor (VEGF) inhibitors or VEGF receptor-targeted agents. TA389 - Gemcitabine, in combination with carboplatin, is not recommended for treating the first recurrence of platinum‑sensitive ovarian cancer. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Gemcitabine (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| hydroxycarbamide | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| idarubicin hydrochloride [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| ifosfamide [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Ifosfamide (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| irinotecan hydrochloride [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA440 |
|||
|
NICE does not recommend this medicine for the following indication
TA440 - Pegylated liposomal irinotecan, in combination with fluorouracil and leucovorin, is not recommended for treating metastatic adenocarcinoma of the pancreas in adults whose disease has progressed after gemcitabine-based therapy. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Irinotecan hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Campto (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| lomustine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| melphalan [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Powder and solvent for solution for injection | |||||
| Melphalan (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| mercaptopurine | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| methotrexate | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral solution | |||||
| Methotrexate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Methotrexate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Metoject PEN (medac UK) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Nordimet (Nordic Pharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Zlatal (Nordic Pharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Methotrexate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| mitomycin [Specialist drug] | Hospital only | ||||
| Powder for solution for injection | |||||
| Mitomycin (Non-proprietary) | Hospital only | ||||
| mitotane [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| mitoxantrone [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Onkotrone (Baxter Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| nelarabine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Atriance (Sandoz Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| oxaliplatin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA100 NICE TA93 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Oxaliplatin (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| paclitaxel [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA55 NICE TA284 NICE TA389 NICE TA476 |
|||
|
NICE does not recommend this medicine for the following indications
TA108 - Paclitaxel, within its licensed indication, is not recommended for the adjuvant treatment of women with early node-positive breast cancer. TA284 - Bevacizumab in combination with paclitaxel and carboplatin is not recommended for the first-line treatment of advanced ovarian cancer (including fallopian tube and primary peritoneal cancer). |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Paclitaxel (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| panobinostat [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA380 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| pegaspargase [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA408 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| pemetrexed [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA124 NICE TA181 NICE TA402 NICE TA190 NICE TA135 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Powder for solution for infusion | |||||
| Pemetrexed (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Alimta (Eli Lilly and Company Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| pentostatin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Nipent (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| pixantrone [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA306 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| procarbazine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| raltitrexed [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| tegafur with gimeracil and oteracil [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| temozolomide [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA23 NICE TA121 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| thiotepa [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| tioguanine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| topotecan [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA183 NICE TA184 NICE TA389 |
|||
|
NICE does not recommend this medicine for the following indication
TA389 - Topotecan is not recommended for treating first recurrence of platinum‑sensitive ovarian cancer, recurrent platinum‑resistant ovarian cancer, or platinum‑refractory ovarian cancer. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Topotecan (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| trabectedin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA185 NICE TA389 |
|||
|
NICE does not recommend this medicine for the following indication
TA389 - Trabectedin in combination with pegylated liposomal doxorubicin hydrochloride (PLDH) is not recommended for treating the first recurrence of platinum‑sensitive ovarian cancer. |
|||||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Powder for solution for infusion | |||||
| Yondelis (Immedica Pharma AB) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| treosulfan [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA640 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Powder for solution for injection | |||||
| Treosulfan (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| tretinoin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| trifluridine with tipiracil [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA405 NICE TA1008 NICE TA852 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| vinblastine sulfate [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Vinblastine sulfate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| vincristine sulfate [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Vincristine sulfate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| vindesine sulfate [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Eldisine (Genus Pharmaceuticals Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| vinorelbine [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for infusion | |||||
| Vinorelbine (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Navelbine (Pierre Fabre Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Malignant disease / Cytotoxic drug-induced side effects | |||||
| dexrazoxane | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder and solvent for solution for infusion | |||||
| Savene (Clinigen Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| folinic acid | Hospital only |
NICE TA212 |
|||
| Solution for injection | |||||
| Folinic acid (Non-proprietary) | Hospital only | ||||
| Sodiofolin (medac UK) | Hospital only | ||||
| levofolinic acid | Not approved for prescribing | ||||
| Solution for injection | |||||
| Isovorin (Pfizer Ltd) | Not approved for prescribing | ||||
| mesna | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Mesna (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Malignant disease / Hyperuricaemia associated with cytotoxic drugs | |||||
| allopurinol | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| febuxostat | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA164 |
|||
| rasburicase | Hospital only | ||||
| Powder and solvent for solution for infusion | |||||
| Fasturtec (Sanofi) | Hospital only | ||||
| Malignant disease / Hormone responsive malignancy | |||||
| abiraterone acetate | Hospital only |
NICE TA259 NICE TA387 NICE TA721 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| apalutamide | Hospital only |
NICE TA740 NICE TA741 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| bicalutamide | Specialist knowledge/initiation | ||||
| buserelin | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Suprefact (Neon Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Spray | |||||
| Suprecur (Neon Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| cyproterone acetate | Specialist knowledge/initiation | ||||
| darolutamide | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA660 NICE TA903 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| degarelix | Hospital only |
NICE TA404 |
|||
| Powder and solvent for solution for injection | |||||
| Firmagon (Ferring Pharmaceuticals Ltd) | Hospital only | ||||
| diethylstilbestrol | Specialist knowledge/initiation | ||||
| enzalutamide | Hospital only |
NICE TA316 NICE TA377 NICE TA580 NICE TA712 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| ethinylestradiol | Not approved for prescribing | ||||
| flutamide | Specialist knowledge/initiation | ||||
| goserelin | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| lanreotide | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| leuprorelin acetate | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Powder and solvent for suspension for injection | |||||
| Prostap 3 DCS (Takeda UK Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Prostap SR DCS (Takeda UK Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| medroxyprogesterone acetate | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| megestrol acetate | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Megestrol acetate (Non-proprietary) | Specialist knowledge/initiation | ||||
| norethisterone | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| octreotide | Hospital only | ||||
|
Agreement between the GP and the hospital
This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing. |
|||||
| Solution for injection | |||||
| Octreotide (Non-proprietary) | Hospital only | ||||
|
Agreement between the GP and the hospital
This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing. |
|||||
| Sandostatin (Novartis Pharmaceuticals UK Ltd) | Hospital only | ||||
|
Agreement between the GP and the hospital
This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing. |
|||||
| Powder and solvent for suspension for injection | |||||
| Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) | Hospital only | ||||
|
Agreement between the GP and the hospital
This product would generally be assigned hospital-only classification, unless an agreement exists between the GP and the hospital for an individual patient, as part of an agreed course of treatment where the trained patient/carer or healthcare professional administers the medicine at home or in the surgery, and/or specifically commissioned for primary care prescribing. |
|||||
| pasireotide | Not approved for prescribing | ||||
| Solution for injection | |||||
| Signifor (Recordati Rare Diseases UK Ltd) | Not approved for prescribing | ||||
| triptorelin | Shared care guideline | ||||
| Powder and solvent for suspension for injection | |||||
| Decapeptyl SR (Ipsen Ltd) | Shared care guideline | ||||
| Gonapeptyl Depot (Ferring Pharmaceuticals Ltd) | Shared care guideline | ||||
| Salvacyl (Ipsen Ltd) | Shared care guideline | ||||
| Malignant disease / Hormone responsive breast cancer | |||||
| anastrozole | Specialist knowledge/initiation | ||||
| exemestane | Specialist knowledge/initiation | ||||
| fulvestrant | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA503 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for injection | |||||
| Fulvestrant (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Faslodex (AstraZeneca UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| letrozole | Specialist knowledge/initiation | ||||
| tamoxifen | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Tamoxifen (Non-proprietary) | Specialist knowledge/initiation | ||||
| toremifene | Hospital only | ||||
| Malignant disease / Photodynamic therapy responsive malignancy | |||||
| temoporfin [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Foscan (Biolitec Pharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Malignant disease / Secondary bone metastases and hypercalcaemia | |||||
| calcitonin (salmon) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Calcitonin (salmon) (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| denosumab | Hospital only |
NICE TA204 NICE TA265 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Solution for injection | |||||
| Xgeva (Amgen Ltd) | Hospital only | ||||
| ibandronic acid | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA464 |
|||
|
Mixed formulary statuses
The JPG agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided that it is used specifically in accordance with NICE Technology Appraisal(s). Specialist knowledge/initiation - Ibandronic acid tablets 150mg for the treatment of osteoporosis in adults Hospital only - Ibandronic acid 3mg solution for injection for the treatment of osteoporosis in adults Non-formulary at HUHFT. Hospital only for providers that have this on their formulary - Ibandronic acid is not approved for secondary bone metastases and hypercalcaemia
|
|||||
| Solution for infusion | |||||
| Ibandronic acid (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Bondronat (Atnahs Pharma UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| pamidronate disodium | Hospital only | ||||
| Solution for infusion | |||||
| Pamidronate disodium (Non-proprietary) | Hospital only | ||||
| sodium clodronate | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| zoledronic acid | Hospital only |
NICE TA464 |
|||
| Infusion | |||||
| Zometa (Phoenix Labs Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| Zoledronic acid (Non-proprietary) | Hospital only | ||||
| Zometa (Phoenix Labs Ltd) | Hospital only | ||||